Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy
August 15, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
Several Former Rosetta Employees and Select Customers Also Join Interpace Parsippany, NJ, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the...
Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
August 09, 2018 16:46 ET
|
Interpace Diagnostics Group, Inc.
Revenue Grew 43% Over the Prior Year’s Quarter and 14% Over the Prior Period Record Quarterly Revenue of $5.5 Million Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt Now Covered...
Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
July 31, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, July 31, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...